Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in AF post-ablation
NCT06111443Phase 3Active, not recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Dec 2023
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in Atrial fibrillation (AFib), sponsored by Chang Gung Memorial Hospital. Started Dec 2023; status: active, not recruiting.
02
Drugs
dapagliflozin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06111443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06111443.